Pharmacoeconomics of Influenza Vaccination for Healthy Working Adults
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 62 (7) , 1013-1024
- https://doi.org/10.2165/00003495-200262070-00003
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The NetherlandsPharmacoEconomics, 2001
- Pharmacoeconomics of Influenza Vaccination in the ElderlyDrugs & Aging, 2000
- Economic Evaluations of Influenza Vaccination in Healthy Working-Age AdultsPharmacoEconomics, 2000
- The Revised Canadian Guidelines for the Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1999
- Economic Impact of Providing Workplace Influenza VaccinationPharmacoEconomics, 1999
- Interpretation of cost-effectiveness analysesJournal of General Internal Medicine, 1998
- Sickness Absence Following a Campaign of Vaccination against Influenza in the WorkplaceOccupational Medicine, 1996
- French Economic Evaluations of Influenza and Influenza VaccinationPharmacoEconomics, 1996
- Cost-effectiveness league tables: More harm than good?Social Science & Medicine, 1993
- Review of Cost-Benefit Analyses of Influenza VaccinePharmacoEconomics, 1992